Parsonage-Turner Syndrome (Neuralgic Amyotrophy): Clinical Overview

Parsonage-Turner syndrome (PTS), or neuralgic amyotrophy, is a rare acute brachial plexopathy featuring severe shoulder pain followed by weakness and atrophy. Immune-mediated mechanism suspected.

Clinical Presentation

  • Phase 1 (Acute pain): Sudden, severe, constant shoulder/upper arm pain—often nocturnal, unrelated to position. Lasts days to weeks.
  • Phase 2 (Weakness/atrophy): As pain subsides, weakness emerges in specific myotomes (supraspinatus, infraspinatus, deltoid, biceps, serratus anterior most common).
  • Sensory changes: Numbness or paresthesia in lateral arm, forearm, thumb (C5–C6 distribution typical).
  • Autonomic: Vasomotor changes, hyperhidrosis.
  • Bilateral in 10–30%; can affect other plexuses (lumbosacral, phrenic).

Triggers and Associations

  • Infections (viral: CMV, EBV, parvovirus, HIV, COVID-19; bacterial)
  • Vaccinations (influenza, tetanus, COVID-19—rare)
  • Surgery, trauma, strenuous exercise
  • Pregnancy, postpartum
  • Autoimmune conditions
  • Idiopathic (no trigger identified)

Diagnosis

  • Clinical: Acute shoulder pain → weakness/atrophy in brachial plexus distribution.
  • EMG/NCS: Confirms axonal loss, localizes to plexus (not root/nerve), excludes mimics (cervical radiculopathy, rotator cuff tear, Pancoast tumor).
  • MRI brachial plexus: T2 hyperintensity, enhancement (acute); fatty infiltration (chronic).
  • Labs: Inflammatory markers, viral serologies, autoantibodies as indicated.

Treatment

  • Pain control: NSAIDs, neuropathic agents (gabapentin, pregabalin, duloxetine), short-course opioids if severe. Corticosteroids (oral/IV) may shorten pain phase if given early (limited evidence).
  • Physical therapy: Maintain range of motion, prevent contractures, scapular stabilization, progressive strengthening as reinnervation occurs.
  • Occupational therapy: Adaptive strategies, assistive devices.
  • Immunomodulation: IVIG, plasma exchange—anecdotal; no RCTs. Consider if severe or progressive.
  • Surgical: Nerve transfers, tendon transfers for fixed deficits after 12–18 months.

Prognosis

  • Pain resolves in weeks to months.
  • Motor recovery: 70–90% achieve functional recovery at 1–3 years.
  • Residual weakness, fatigue, pain in 30–50%.
  • Recurrence: 5–10%.

Early diagnosis avoids unnecessary shoulder surgery. Neurology or physiatry referral recommended.

Genetic Disorders - Related Articles